National HealthCare (NHC)
(Delayed Data from AMEX)
$91.28 USD
+0.51 (0.56%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $91.27 -0.01 (-0.01%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NHC 91.28 +0.51(0.56%)
Will NHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NHC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NHC
Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting
Jefferies Reaffirms Their Hold Rating on New Hope Corporation Limited (NHPEF)
JPMorgan Adjusts Stance on New Hope Corp
Ex-Dividend Reminder: National Healthcare, Danaher and DENTSPLY SIRONA
Analyst Issues Sell Rating for New Hope Corporation Limited Citing Valuation Concerns and Market Trends